Speaking about Enta's AM discussions, Luly stated that similar to the HCV treatment, he expects that NASA and RSV treatments will be drug combinations. Consequently, ENTA will be looking for a partner(s) with scientific expertise to complement their own expertise.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.